These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 8494359)

  • 1. Activities of fluoroquinolone, macrolide, and aminoglycoside drugs combined with inhibitors of glycosylation and fatty acid and peptide biosynthesis against Mycobacterium avium.
    Barrow WW; Wright EL; Goh KS; Rastogi N
    Antimicrob Agents Chemother; 1993 Apr; 37(4):652-61. PubMed ID: 8494359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential drug targets for Mycobacterium avium defined by radiometric drug-inhibitor combination techniques.
    Rastogi N; Goh KS; Wright EL; Barrow WW
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2287-95. PubMed ID: 7840559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A unique phenylalanine-containing lipopeptide isolated from a rough-colony variant of Mycobacterium avium.
    Rivière M; Puzo G; Wright EL; Barrow WW
    Eur J Biochem; 1996 Oct; 241(2):682-90. PubMed ID: 8917472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of rifabutin, clarithromycin, ethambutol, sparfloxacin and amikacin, alone and in combination, against Mycobacterium avium complex in human macrophages.
    Pellegrin I; Maugein J; Lapeyre C; Barbeau P; Leng B; Pellegrin JL
    J Antimicrob Chemother; 1996 Mar; 37(3):501-10. PubMed ID: 9182107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro susceptibility of Mycobacterium avium complex to the new fluoroquinolone sparfloxacin (CI-978; AT-4140) and comparison with ciprofloxacin.
    Yajko DM; Sanders CA; Nassos PS; Hadley WK
    Antimicrob Agents Chemother; 1990 Dec; 34(12):2442-4. PubMed ID: 2088204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of aminoglycosides, clofazimine, d-cycloserine and dapsone against 83 Mycobacterium avium complex clinical isolates.
    Huang CC; Wu MF; Chen HC; Huang WC
    J Microbiol Immunol Infect; 2018 Oct; 51(5):636-643. PubMed ID: 28705770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activities of fourteen antimicrobial agents against drug susceptible and resistant clinical isolates of Mycobacterium tuberculosis and comparative intracellular activities against the virulent H37Rv strain in human macrophages.
    Rastogi N; Labrousse V; Goh KS
    Curr Microbiol; 1996 Sep; 33(3):167-75. PubMed ID: 8672093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the core lipopeptide of the glycopeptidolipid surface antigens in rough mutants of Mycobacterium avium.
    Belisle JT; McNeil MR; Chatterjee D; Inamine JM; Brennan PJ
    J Biol Chem; 1993 May; 268(14):10510-6. PubMed ID: 8486703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of moxifloxacin by itself and in combination with ethambutol, rifabutin, and azithromycin in vitro and in vivo against Mycobacterium avium.
    Bermudez LE; Inderlied CB; Kolonoski P; Petrofsky M; Aralar P; Wu M; Young LS
    Antimicrob Agents Chemother; 2001 Jan; 45(1):217-22. PubMed ID: 11120969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postantibiotic effect of amikacin, rifampin, sparfloxacin, clofazimine and clarithromycin against Mycobacterium avium.
    Horgen L; Legrand E; Rastogi N
    Res Microbiol; 1997 Nov; 148(8):673-81. PubMed ID: 9765852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimycobacterial agents differ with respect to their bacteriostatic versus bactericidal activities in relation to time of exposure, mycobacterial growth phase, and their use in combination.
    Bakker-Woudenberg IA; van Vianen W; van Soolingen D; Verbrugh HA; van Agtmael MA
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2387-98. PubMed ID: 15917538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro, ex-vivo and in vivo activities of ethambutol and sparfloxacin alone and in combination against mycobacteria.
    Kaur D; Khuller GK
    Int J Antimicrob Agents; 2001 Jan; 17(1):51-5. PubMed ID: 11137649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal infection involving Mycobacterium avium presenting with three distinct colony morphotypes.
    Wright EL; Zywno-van Ginkel S; Rastogi N; Barrow WW
    J Clin Microbiol; 1996 Oct; 34(10):2475-8. PubMed ID: 8880503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Extracellular and intracellular activity of sparfloxacin against Mycobacterium avium complex and Mycobacterium xenopi].
    Gevaudan MJ; Bollet C; Mallet MN; de Lamballerie X; Sambuc R; de Micco P
    Pathol Biol (Paris); 1992 May; 40(5):443-9. PubMed ID: 1323093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of subinhibitory concentrations of dapsone alone and in combination with cell-wall inhibitors against Mycobacterium avium complex organisms.
    Rastogi N; Goh KS; Labrousse V
    Eur J Clin Microbiol Infect Dis; 1993 Dec; 12(12):954-8. PubMed ID: 8187794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. French multicenter study involving eight test sites for radiometric determination of activities of 10 antimicrobial agents against Mycobacterium avium complex.
    Rastogi N; Bauriaud RM; Bourgoin A; Carbonnelle B; Chippaux C; Gevaudan MJ; Goh KS; Moinard D; Roos P
    Antimicrob Agents Chemother; 1995 Mar; 39(3):638-44. PubMed ID: 7793865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CI-960 (PD127391 or AM-1091), sparfloxacin, WIN 57273, and isepamicin activity against clinical isolates of Mycobacterium avium-intracellularae complex, M. chelonae, and M. fortuitum.
    Barrett MS; Jones RN; Erwin ME; Koontz FP
    Diagn Microbiol Infect Dis; 1992 Feb; 15(2):169-71. PubMed ID: 1315233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postantibiotic effects of rifampin, amikacin, clarithromycin and ethambutol used alone or in various two-, three- and four-drug combinations against Mycobacterium avium.
    Horgen L; Legrand E; Rastogi N
    FEMS Immunol Med Microbiol; 1999 Jan; 23(1):37-44. PubMed ID: 10030545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spectrum of activity of levofloxacin against nontuberculous mycobacteria and its activity against the Mycobacterium avium complex in combination with ethambutol, rifampin, roxithromycin, amikacin, and clofazimine.
    Rastogi N; Goh KS; Bryskier A; Devallois A
    Antimicrob Agents Chemother; 1996 Nov; 40(11):2483-7. PubMed ID: 8913450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Killing by antimycobacterial agents of AIDS-derived strains of Mycobacterium avium complex inside cells of the mouse macrophage cell line J774.
    Yajko DM; Nassos PS; Sanders CA; Hadley WK
    Am Rev Respir Dis; 1989 Nov; 140(5):1198-203. PubMed ID: 2817581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.